These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20736460)

  • 21. Trials and tribulations: a primer on successfully navigating the waters of the Food and Drug Administration.
    Feinsod M; Chambers WA
    Ophthalmology; 2004 Oct; 111(10):1801-6. PubMed ID: 15465539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Timing of patent filing and market exclusivity.
    Dunn MK
    Nat Rev Drug Discov; 2011 Jul; 10(7):487-8. PubMed ID: 21720399
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccine INDs: review of clinical holds.
    Miller DL; Ross JJ
    Vaccine; 2005 Jan; 23(9):1099-101. PubMed ID: 15629351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation and review of DNA vaccine products.
    Smith HA
    Dev Biol (Basel); 2000; 104():57-62. PubMed ID: 11713825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The HIV/AIDS vaccine researchers' orientation to the process of preparing a US FDA application for an investigational new drug (IND): what it is all about and how you start by preparing for your pre-IND meeting.
    Shapiro SZ
    Vaccine; 2002 Jan; 20(9-10):1261-80. PubMed ID: 11818145
    [No Abstract]   [Full Text] [Related]  

  • 26. Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006.
    Wang Y; Bhattaram AV; Jadhav PR; Lesko LJ; Madabushi R; Powell JR; Qiu W; Sun H; Yim DS; Zheng JJ; Gobburu JV
    J Clin Pharmacol; 2008 Feb; 48(2):146-56. PubMed ID: 18199891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease, drugs, and delay: suggested changes for the FDA.
    Petricciani JC
    Clin Res; 1990 Dec; 38(4):701-3. PubMed ID: 2276258
    [No Abstract]   [Full Text] [Related]  

  • 28. Investigational new drugs submitted to the Food and Drug Administration that are placed on clinical hold: the experience of the Office of Cellular, Tissue and Gene Therapy.
    Wonnacott K; Lavoie D; Fiorentino R; McIntyre M; Huang Y; Hirschfeld S
    Cytotherapy; 2008; 10(3):312-6. PubMed ID: 18418776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Looking abroad: clinical drug trials.
    Hathaway CR; Manthei JR; Haas JB; Scherer CA
    Food Drug Law J; 2008; 63(3):673-81. PubMed ID: 19031667
    [No Abstract]   [Full Text] [Related]  

  • 30. Investigational new drug application; exception from informed consent; technical amendment--FDA. Final rule.
    Fed Regist; 1997 Jun; 62(115):32479. PubMed ID: 10169828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality assurance operations: good clinical practices.
    Castellion AW
    Drug Inf J; 1983; 17(1):25-9. PubMed ID: 10262248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Food and Drug Administration audit of foreign clinical trials.
    Sloboda W; Lisook AB
    Psychopharmacol Bull; 1987; 23(1):193-5. PubMed ID: 3602320
    [No Abstract]   [Full Text] [Related]  

  • 33. Regulatory Affairs 101: Introduction to Investigational New Drug Applications and Clinical Trial Applications.
    Chiodin D; Cox EM; Edmund AV; Kratz E; Lockwood SH
    Clin Transl Sci; 2019 Jul; 12(4):334-342. PubMed ID: 30884199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toward a New Era of Trust and Transparency in Clinical Trials.
    Hudson KL; Lauer MS; Collins FS
    JAMA; 2016 Oct; 316(13):1353-1354. PubMed ID: 27636028
    [No Abstract]   [Full Text] [Related]  

  • 35. The web of clinical trial registration obligations: have foreign clinical trials been caught?
    Hathaway CR; Manthei JR; Haas JB; Meltzer ED
    Food Drug Law J; 2009; 64(2):261-75. PubMed ID: 19999283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of research: is it a drug trial or a supplement trial?
    Chen ST
    Fitoterapia; 2011 Jan; 82(1):14-6. PubMed ID: 21073930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The globalization of clinical trials: a growing challenge in protecting human subjects: executive summary (2001).
    Department of Health and Human Services, Office of the Inspector General, USA
    J Int Bioethique; 2003; 14(1-2):165-9. PubMed ID: 15035253
    [No Abstract]   [Full Text] [Related]  

  • 38. Patient group seeks overhaul of FDA clinical trial system in court.
    Hede K
    J Natl Cancer Inst; 2006 Sep; 98(18):1268-70. PubMed ID: 16985242
    [No Abstract]   [Full Text] [Related]  

  • 39. Good clinical practice in clinical drug trials--what you need to know.
    Soyebi K; Abosede ; Coker HA; Osuntoki ; Oyibos W; Keri H; Ogunsola S
    Nig Q J Hosp Med; 2008; 18(2):104-12. PubMed ID: 19068563
    [No Abstract]   [Full Text] [Related]  

  • 40. Biotech unruffled by setbacks.
    Glaser V
    Nat Biotechnol; 1997 Jul; 15(7):610-1. PubMed ID: 9219254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.